This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2010-2018.
Location History:
- Loughborough, GB (2010)
- Leicestershire, GB (2010)
- Macclesfield, GB (2016)
- Cheshire, GB (2018)
Company Filing History:
Years Active: 2010-2018
Title: The Innovative Contributions of Philip Cornwall in Pharmacology
Introduction
Philip Cornwall, an esteemed inventor based in Cheshire, GB, has made significant strides in the field of pharmacology with his groundbreaking inventions. With a total of 4 patents to his name, Cornwall has been instrumental in developing novel pharmaceutical compounds aimed at improving vascular function through innovative receptor modulation techniques.
Latest Patents
Among his latest contributions, Cornwall has focused on the development of benzoxazinone amides as mineralocorticoid receptor modulators. These derivatives, outlined in his patents, possess the formula (I) and include pharmaceutically acceptable salts. The potential therapeutic uses of these compounds include reducing oxidative stress in the endothelial cells, thus enhancing vascular function. Furthermore, his patents detail the methods for preparing such compounds, as well as the pharmaceutical compositions that incorporate them, illustrating his commitment to advancing therapeutic options in medicine.
Career Highlights
Currently employed at AstraZeneca, one of the leading pharmaceutical companies in the world, Philip Cornwall’s work is pivotal in the development of cutting-edge therapies. His extensive research and innovations in mineralocorticoid receptor modulation have positioned him as a key figure in his field, contributing not only to the scientific community but also to the wellness of patients who may benefit from his discoveries.
Collaborations
Philip Cornwall collaborates with distinguished colleagues, including Gavin O'Mahony and Michael Kossenjans. Together, they form a dynamic team that integrates diverse expertise, enhancing the potential for successful innovations and advancing the frontiers of pharmaceutical research.
Conclusion
In conclusion, Philip Cornwall's contributions to pharmacology exemplify the transformative power of innovation. His work on benzoxazinone amides showcases the intersection of creativity and scientific inquiry, paving the way for improved therapeutic methodologies. As his career continues to evolve, Cornwall remains a vital contributor to the ongoing quest for medical advancements.